Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02432092 · ClinicalTrials.gov registry record
Pediatric Cardiomyopathy Mutation Analysis
A clinical trial of Cardiomyopathies and Hypertrophic Cardiomyopathy, sponsored by Indiana University.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT02432092: Recruiting study of Cardiomyopathies and Hypertrophic Cardiomyopathy, sponsored by Indiana University.
NCT02432092 is a study of Cardiomyopathies and Hypertrophic Cardiomyopathy that is actively recruiting participants, run by Indiana University. The registered enrollment target is 300 participants, below the 618-participant average among 17 other Cardiomyopathies trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02432092, a study of Cardiomyopathies and Hypertrophic Cardiomyopathy, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this protocol is to obtain information from individuals with cardiomyopathy and from their families in order to elucidate the molecular genetics of this disorder. This will provide the basis for future genetic counseling as well as contribute to elucidating the biology of normal and abnormal cardiac function.
Conditions Studied
Study Locations (1)
Indiana
- IU School of Medicine - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2014-04 |
| Est. Completion | 2030-12-31 |
What NCT02432092 shows while recruiting
NCT02432092 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 618-participant average among 17 other Cardiomyopathies trials with a reported enrollment target (51% lower).
The record links to 6 conditions, with Cardiomyopathies appearing as the primary indexed condition, and to 0 interventions.
NCT02432092 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT02432092 about?
NCT02432092 is a clinical study titled "Pediatric Cardiomyopathy Mutation Analysis". The goal of this protocol is to obtain information from individuals with cardiomyopathy and from their families in order to elucidate the molecular genetics of this disorder. This will provide the basis for future genetic counseling as well as contribute to elucidating the biology of normal and abno...
What is the current status of trial NCT02432092?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2014-04. Estimated completion is 2030-12-31.
What conditions does trial NCT02432092 study?
This clinical trial studies the following conditions: Cardiomyopathies, Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy, Restrictive Cardiomyopathy.
Who is sponsoring clinical trial NCT02432092?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02432092 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiomyopathies
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02432092's enrollment target sits among peer trials
300 7th of 17 higher than 10 of 17 other Cardiomyopathies trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiomyopathies trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cardiovascular Multimodality Imaging Study
RECRUITING
-
Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia
RECRUITING · Phase 1
-
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
RECRUITING · Phase 4
-
PKP2-ACM Natural History Study
RECRUITING
-
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
RECRUITING
-
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia